Angelique Bordey was a Postdoctoral Fellow at the University of Alabama. She received an MS degree in Chemistry from the National School of Engineering in Lyon (ESCIL), France. She graduated from Louis Pasteur University with an MS in Neurophysiology and a PhD in Neuroscience. She is currently a Professor of Neurosurgery, and Cellular & Molecular Physiology at Yale University. She also is an active participant in the teaching and training of graduate and medical students at Yale School of Medicine. She serves as an Editor for several journals, has served on the advisory board of CURE epilepsy and the Tuberous Sclerosis Complex (TSC) Alliance preclinical consortium, and is now a board member for the TSC Alliance. She has served as a permanent member on several grant review committees and NIH study sections. Finally, she is a McKnight awardee and holds several grants as well as patents for the treatment of epilepsy. Her research interests include Autistic Disorder; Epilepsy; Central Nervous System Diseases; Cortical Malformations; Neurologic Manifestations; mTOR; Cortical Development; Neurogenesis.